Jove
Visualize
联系我们

相关概念视频

Angina IV: Management01:26

Angina IV: Management

222
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
222
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

206
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
206
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

1.3K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.3K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

1.3K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.3K
Angina V: Nursing Management01:20

Angina V: Nursing Management

278
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
278
Angina II: Classification01:27

Angina II: Classification

308
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
308

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Treatment of angina pectoris: lessons from trials.

European heart journal·2026
Same author

Contrast-Derived Index of Microcirculatory Resistance (cIMR): A Novel Index for Measuring Coronary Microvascular Resistance.

Circulation. Cardiovascular interventions·2026
Same author

Intracoronary Imaging for the Management of Vulnerable Plaques.

Journal of clinical medicine·2026
Same author

Barriers preventing consideration of environmental risk factors by cardiologists.

European heart journal·2026
Same author

Non-invasive Coronary Functional Tests in Patients with Angina and Non-obstructive Coronary Artery Disease.

European cardiology·2026
Same author

Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapies.

Nature reviews. Cardiology·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jan 10, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.7K

针对耐火性心房痛的基于设备的治疗方法

Andrea Caffè1, Rocco A Montone1,2

  • 1Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, 00168 Rome, Italy.

Journal of clinical medicine
|November 27, 2025
PubMed
概括

基于设备的疗法,如冠状动脉鼻腔减缓器 (CSR),为患有持续性 angina 的患者提供了新的希望. 虽然有效缓解症状,但需要进一步的研究,以充分理解它们的机制和优化结果.

关键词:
冠状动脉鼻减速器 冠状动脉鼻减速器慢性冠状动脉综合征 慢性冠状动脉综合征基于设备的疗法.增强的外部对冲动.身体外冲击波心肌神经复血管化缺血与非阻塞性冠状动脉 (INOCA)心肌 perfusion 影像成像,用于心肌 perfusion 的成像.耐火性心肌痛是一种心肌痛.脊髓刺激 脊髓刺激稳定的心肌痛 (angina)

更多相关视频

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.7K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.1K

相关实验视频

Last Updated: Jan 10, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.7K
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.7K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.1K

科学领域:

  • 心脏病学 心脏病学
  • 医疗器械 医疗器械
  • 缺血性心脏病是一种心脏病.

背景情况:

  • 许多患有缺血性心脏病的患者经历了持续性 angina 尽管最佳的医疗治疗和再血管化.
  • 这凸显了对新且有效的治疗策略的重大未满足需求.

研究的目的:

  • 为了审查目前的基于设备的治疗Angina的景观.
  • 专注于支持冠状动脉鼻腔减缓器 (CSR) 和其他设备干预的证据.
  • 讨论机制,结果和未来的研究方向.

主要方法:

  • 随机试验和注册表的综述,评估基于器件的治疗方法.
  • 讨论病理生理机制和临床结果.
  • 探索新兴的基于设备的方法.

主要成果:

  • 冠状动脉鼻腔减轻器 (CSR) 显示出有前途,改善心痛症状和生活质量,具有良好的安全性.
  • 症状缓解和心肌输液的客观测量之间存在断裂,表明不完全理解的机制.
  • 其他设备,如增强的外部反推力,神经调制和冲击波疗法也在调查中.

结论:

  • 基于设备的疗法代表了在心痛管理中不断发展的前沿.
  • 将患者报告的结果与生理和成像评估相结合,对于完善指示和改善长期结果至关重要.
  • 这些疗法有可能改善耐火性心痛患者的治疗结果.